Skip to main content
. 2017 Apr 3;2(1):58–69. doi: 10.1002/btm2.10061

Figure 7.

Figure 7

Performance of the KBI Biopharma platform DSP approach for several mAbs.

(a) HMW clearance, (b) HCP clearance